MTX652 has advanced through preclinical regulatory toxicology studies and is ready for a phase 1 trial
In response to a decline in vaccine coverage, the Office for Health Improvement and Disparities (OHID), supported by […]
Updated Date: Wed, 23 Mar 2022 00:00:00 EDT
Updated Date: Wed, 23 Mar 2022 00:00:00 EDT
NHS and care staff, as well as some vulnerable patients, will continue to have access to free testing […]
The World Health Organization has issued a list of 63 recommendations that governments around the world should aim […]
Until now, proteins have been the target of most medications for the prevention and treatment of human disease. […]
Climate change should be embedded in medical schools’ curriculums to help doctors understand the climate emergency and its […]
Second booster doses against covid-19 for Americans aged over 50 and for certain immunocompromised people aged over 12, […]
Throughout the pandemic, the UK’s covid-19 data systems have been guiding global as well as local policies. The […]